Position in IDXGD
as of Dec 31, 2020
· filed Feb 12, 2021
Position Value
$0
+$0 QoQ
Shares Held
80,612
+16.8% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IDXGD Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $73,049,367,263 across 41 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
34,133,702 | $19,778,773,621 | |
| 2 | DHR |
Danaher Corp /De/
|
60,978,360 | $13,959,166,168 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
9,945,328 | $6,728,312,749 | |
| 4 | A |
Agilent Technologies, Inc.
|
34,105,783 | $4,640,773,889 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
19,650,532 | $4,429,426,415 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
2,540,511 | $3,541,954,775 | |
| 7 | WAT |
Waters Corp /De/
|
7,469,936 | $2,837,305,789 | |
| 8 | NTRA |
Natera, Inc.
|
12,306,424 | $2,819,278,671 |
All Filings in IDXGD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2020-12-31 | — | 80,612 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | — | 69,029 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | — | 34,364 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | — | 118,978 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||